Pharmacist Opioid & Pain Management Podcast 30m

Low-dose naltrexone (LDN) is generating growing interest as a potential therapy for conditions such as chronic pain and immune-related disorders. This episode offers a foundational overview of what LDN is, how it’s thought to work, where current evidence stands, and how pharmacists may encounter it in practice. Learn what pharmacists need to know to confidently approach patient questions about LDN and how it fits into current conversations in pharmacy and patient care.

Learn More.

Course Details

Low-dose naltrexone (LDN) is generating growing interest as a potential therapy for conditions such as chronic pain and immune-related disorders. This episode offers a foundational overview of what LDN is, how it’s thought to work, where current evidence stands, and how pharmacists may encounter it in practice. Learn what pharmacists need to know to confidently approach patient questions about LDN and how it fits into current conversations in pharmacy and patient care.

Upon successful completion of this course, learners should be able to:
1. Define low-dose naltrexone (LDN) and describe how it differs from traditional naltrexone dosing. 
2. Identify proposed mechanisms of action and areas of emerging interest related to LDN use in practice.

Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

Michelle Moser, RPh
Retired Compounding Pharmacist

Joshua Davis Kinsey has no relevant financial relationships to disclose. 

Michelle Moser was a volunteer board member for LDN Research Trust (ended June 2025), a board member for Alliance for Pharmacy Compounding (ended September 2024), and an employee of Revelation Pharma (ended June 2024). All relevant financial relationships have been mitigated.   

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: August 25, 2025
Planned Expiration Date: August 25, 2026

Copyright 2025, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  


Universal Activity Number (UAN): 0107-0000-25-275-H01-P
Application-based CPE Activity
Planned Expiration Date: August 25, 2026

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.